Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.

1.	Spotswood L. Spruance, Julia E. Reid, Michael Grace, Matthew Samore
		Hazard Ratio in Clinical Trials
		Antimicrob. Agents Chemother. Aug 01, 2004; 48: 2787-2792. (In "Minireviews")   [Full Text]     [PDF]
2.	Tuberculosis Drug Screening Program
		Search for New Drugs for Treatment of Tuberculosis
		Antimicrob. Agents Chemother. Jul 01, 2001; 45: 1943-1946. (In "Guest Commentary")   [Full Text]     [PDF]
3.	John Gisby, Joanna Bryant
		Efficacy of a New Cream Formulation of Mupirocin: Comparison with Oral and Topical Agents in Experimental Skin Infections
		Antimicrob. Agents Chemother. Feb 01, 2000; 44: 255-260. (In "Experimental Therapeutics")   [Abstract]     [Full Text]     [PDF]
4.	Brigitte Montes, Michel Segondy
		Amino Acid Substitutions at Position 69 of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Are Frequent in Zalcitabine-Naive Antiretroviral-Drug-Experienced Patients
		Antimicrob. Agents Chemother. Sep 01, 2002; 46: 3110-3111. (In "Letters")   [Full Text]     [PDF]
5.	J. M. Rolain, P. Brouqui, J. E. Koehler, C. Maguina, M. J. Dolan, D. Raoult
		Recommendations for Treatment of Human Infections Caused by Bartonella Species
		Antimicrob. Agents Chemother. Jun 01, 2004; 48: 1921-1933. (In "Minireviews")   [Full Text]     [PDF]
6.	Cody C. Cain, Dongho Lee, Robert H. Waldo III, Alexis T. Henry, Earl J. Casida, Mansukh C. Wani, Monroe E. Wall, Nicholas H. Oberlies, Joseph O. Falkinham III
		Synergistic Antimicrobial Activity of Metabolites Produced by a Nonobligate Bacterial Predator
		Antimicrob. Agents Chemother. Jul 01, 2003; 47: 2113-2117. (In "Susceptibility")   [Abstract]     [Full Text]     [PDF]
7.	Sarah Palmer, Robert W. Shafer, Thomas C. Merigan
		Hydroxyurea Enhances the Activities of Didanosine, 9-[2-(Phosphonylmethoxy)ethyl]adenine, and 9-[2-(Phosphonylmethoxy)propyl]adenine against Drug-Susceptible and Drug-Resistant Human Immunodeficiency Virus Isolates
		Antimicrob. Agents Chemother. Aug 01, 1999; 43: 2046-2050. (In "Antiviral Agents")   [Abstract]     [Full Text]     [PDF]
8.	Federico Perez, Andrea M. Hujer, Kristine M. Hujer, Brooke K. Decker, Philip N. Rather, Robert A. Bonomo
		Global Challenge of Multidrug-Resistant Acinetobacter baumannii
		Antimicrob. Agents Chemother. Oct 01, 2007; 51: 3471-3484. (In "Minireviews")   [Full Text]     [PDF]
9.	DP Nicolau, CD Freeman, PP Belliveau, CH Nightingale, JW Ross, R Quintiliani
		Experience with a once-daily aminoglycoside program administered to 2,184 adult patients
		Antimicrob. Agents Chemother. Mar 01, 1995; 39: 650-655. (In "Articles")   [Abstract]     [PDF]
10.	Leta Posho, Laurence Delbos-Bocage, Delphine Gueylard, Robert Farinotti, Claude Carbon
		Effects of Salmonella typhimurium Infection and Ofloxacin Treatment on Glucose and Glutamine Metabolism in Caco-2/TC-7 Cells
		Antimicrob. Agents Chemother. Nov 01, 1998; 42: 2950-2955. (In "Pharmacology")   [Abstract]     [Full Text]     [PDF]
11.	Aurélie Thiolas, Claude Bollet, Bernard La Scola, Didier Raoult, Jean-Marie Pagès
		Successive Emergence of Enterobacter aerogenes Strains Resistant to Imipenem and Colistin in a Patient
		Antimicrob. Agents Chemother. Apr 01, 2005; 49: 1354-1358. (In "Mechanisms Of Resistance")   [Abstract]     [Full Text]     [PDF]
12.	Alexander Sulakvelidze, Zemphira Alavidze, J. Glenn Morris
		Bacteriophage Therapy
		Antimicrob. Agents Chemother. Mar 01, 2001; 45: 649-659. (In "Minireviews")   [Full Text]     [PDF]
13.	Thomas P. Lodise, Ben Lomaestro, Jeffrey Graves, G. L. Drusano
		Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
		Antimicrob. Agents Chemother. Apr 01, 2008; 52: 1330-1336. (In "Clinical Therapeutics")   [Abstract]     [Full Text]     [PDF]
14.	George Jacoby, Vincent Cattoir, David Hooper, Luis Martínez-Martínez, Patrice Nordmann, Alvaro Pascual, Laurent Poirel, Minggui Wang
		qnr Gene Nomenclature
		Antimicrob. Agents Chemother. Jul 01, 2008; 52: 2297-2299. (In "Guest Commentary")   [Full Text]     [PDF]
15.	John Weigelt, Kamal Itani, Dennis Stevens, William Lau, Matthew Dryden, Charles Knirsch, the Linezolid CSSTI Study Group
		Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections
		Antimicrob. Agents Chemother. Jun 01, 2005; 49: 2260-2266. (In "Clinical Therapeutics")   [Abstract]     [Full Text]     [PDF]
16.	David J. Weber, William A. Rutala, Emily E. Sickbert-Bennett
		Outbreaks Associated with Contaminated Antiseptics and Disinfectants
		Antimicrob. Agents Chemother. Dec 01, 2007; 51: 4217-4224. (In "Minireviews")   [Full Text]     [PDF]
17.	Stuart B. Levy
		Genome Size and Antibiotic Resistance
		Antimicrob. Agents Chemother. Jul 01, 2008; 52: 2696-2696. (In "Letters")   [Full Text]     [PDF]
18.	Gary D. Ewart, Najla Nasr, Hassan Naif, Graeme B. Cox, Anthony L. Cunningham, Peter W. Gage
		Potential New Anti-Human Immunodeficiency Virus Type 1 Compounds Depress Virus Replication in Cultured Human Macrophages
		Antimicrob. Agents Chemother. Jun 01, 2004; 48: 2325-2330. (In "Antiviral Agents")   [Abstract]     [Full Text]     [PDF]
19.	Todd P. Levin, Byungse Suh, Peter Axelrod, Allan L. Truant, Thomas Fekete
		Potential Clindamycin Resistance in Clindamycin-Susceptible, Erythromycin-Resistant Staphylococcus aureus: Report of a Clinical Failure
		Antimicrob. Agents Chemother. Mar 01, 2005; 49: 1222-1224. (In "Mechanisms Of Resistance")   [Abstract]     [Full Text]     [PDF]
20.	Reanne Hughes, Simon Kilvington
		Comparison of Hydrogen Peroxide Contact Lens Disinfection Systems and Solutions against Acanthamoeba polyphaga
		Antimicrob. Agents Chemother. Jul 01, 2001; 45: 2038-2043. (In "Susceptibility")   [Abstract]     [Full Text]     [PDF]

= from the current issue

Last Updated: 07/02/2008 22:04:04